130 related articles for article (PubMed ID: 20367356)
1. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases.
Cavalheiro S; Di Rocco C; Valenzuela S; Dastoli PA; Tamburrini G; Massimi L; Nicacio JM; Faquini IV; Ierardi DF; Silva NS; Pettorini BL; Toledo SR
Neurosurg Focus; 2010 Apr; 28(4):E12. PubMed ID: 20367356
[TBL] [Abstract][Full Text] [Related]
2. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma.
Cavalheiro S; Dastoli PA; Silva NS; Toledo S; Lederman H; da Silva MC
Childs Nerv Syst; 2005 Aug; 21(8-9):719-24. PubMed ID: 16133276
[TBL] [Abstract][Full Text] [Related]
3. Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon.
Dastoli PA; Nicácio JM; Silva NS; Capellano AM; Toledo SR; Ierardi D; Cavalheiro S
Arq Neuropsiquiatr; 2011 Feb; 69(1):50-5. PubMed ID: 21359423
[TBL] [Abstract][Full Text] [Related]
4. [Pediatric craniopharyngioma: long-term results in 61 cases].
Pancucci G; Massimi L; Caldarelli M; D'Angelo L; Sturiale C; Tamburrini G; Tufo T; Di Rocco C
Minerva Pediatr; 2007 Jun; 59(3):219-31. PubMed ID: 17519867
[TBL] [Abstract][Full Text] [Related]
5. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG
J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012
[TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon-α-2b for children with recurrent craniopharyngioma.
Yeung JT; Pollack IF; Panigrahy A; Jakacki RI
J Neurosurg Pediatr; 2012 Dec; 10(6):498-503. PubMed ID: 23061825
[TBL] [Abstract][Full Text] [Related]
7. Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape.
Mrowczynski OD; Langan ST; Rizk EB
Clin Neurol Neurosurg; 2018 Mar; 166():124-130. PubMed ID: 29408768
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.
Hader WJ; Steinbok P; Hukin J; Fryer C
Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639
[TBL] [Abstract][Full Text] [Related]
9. Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report.
Sharma J; Bonfield CM; Singhal A; Hukin J; Steinbok P
J Neurosurg Pediatr; 2015 Sep; 16(3):301-4. PubMed ID: 26023721
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.
Ierardi DF; Fernandes MJ; Silva IR; Thomazini-Gouveia J; Silva NS; Dastoli P; Toledo SR; Cavalheiro S
Childs Nerv Syst; 2007 Sep; 23(9):1041-6. PubMed ID: 17593372
[TBL] [Abstract][Full Text] [Related]
11. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report.
Cavalheiro S; Sparapani FV; Franco JO; da Silva MC; Braga FM
J Neurosurg; 1996 Jan; 84(1):124-6. PubMed ID: 8613819
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note.
Pettorini BL; Tamburrini G; Massimi L; Caldarelli M; Di Rocco C
J Neurosurg Pediatr; 2009 Sep; 4(3):245-8. PubMed ID: 19772408
[TBL] [Abstract][Full Text] [Related]
13. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.
Kilday JP; Caldarelli M; Massimi L; Chen RH; Lee YY; Liang ML; Parkes J; Naiker T; van Veelen ML; Michiels E; Mallucci C; Pettorini B; Meijer L; Dorfer C; Czech T; Diezi M; Schouten-van Meeteren AYN; Holm S; Gustavsson B; Benesch M; Müller HL; Hoffmann A; Rutkowski S; Flitsch J; Escherich G; Grotzer M; Spoudeas HA; Azquikina K; Capra M; Jiménez-Guerra R; MacDonald P; Johnston DL; Dvir R; Constantini S; Kuo MF; Yang SH; Bartels U
Neuro Oncol; 2017 Oct; 19(10):1398-1407. PubMed ID: 28499018
[TBL] [Abstract][Full Text] [Related]
14. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas.
Mottolese C; Stan H; Hermier M; Berlier P; Convert J; Frappaz D; Lapras C
Childs Nerv Syst; 2001 Dec; 17(12):724-30. PubMed ID: 11862438
[TBL] [Abstract][Full Text] [Related]
15. Does the choice of surgical approach to insert an intratumoral catheter influence the results of intratumoral cystic treatment?
Zanon N; Cavalheiro S; da Silva MC
Surg Neurol; 2008 Jul; 70(1):66-9; discussion 69. PubMed ID: 18207525
[TBL] [Abstract][Full Text] [Related]
16. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
[TBL] [Abstract][Full Text] [Related]
17. Does chemotherapy have a role in the management of craniopharyngioma?
Hargrave DR
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():407-12. PubMed ID: 16700318
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children.
Takahashi H; Yamaguchi F; Teramoto A
Childs Nerv Syst; 2005 Aug; 21(8-9):701-4. PubMed ID: 15928963
[TBL] [Abstract][Full Text] [Related]
19. Intracystic treatments for craniopharyngioma.
Steinbok P; Hukin J
Neurosurg Focus; 2010 Apr; 28(4):E13. PubMed ID: 20367357
[TBL] [Abstract][Full Text] [Related]
20. Neuroradiological findings of bleomycin leakage in cystic craniopharyngioma. Report of three cases.
Lafay-Cousin L; Bartels U; Raybaud C; Kulkarni AV; Guger S; Huang A; Bouffet E
J Neurosurg; 2007 Oct; 107(4 Suppl):318-23. PubMed ID: 17941498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
